Peptide/Conjugate | logP | Human intestinal absorption | BBB penetration | PgP inhibitor | PgP substrate | Pfizer rule | MDCK permeability | hERG blockers |
---|---|---|---|---|---|---|---|---|
NPFF | 0.884 | 0.994 | 0.003 | 0.912 | 0.503 | Accepted | 9.25E-05 | 0.03 |
Betanin-NPFF | − 0.054 | 1 | 0.005 | 0 | 0.695 | Accepted | 4.47E-05 | 0.006 |
Betanin-di-NPFF | 1.056 | 1 | 0 | 0 | 0.294 | Accepted | 1.66E-05 | 0 |
Betanin-tri-NPFF | 2.574 | 1 | 0 | 0 | 0.149 | Accepted | 1.53E-05 | 0 |
Gallate-NPFF | 0.806 | 1 | 0.001 | 0.192 | 0.852 | Accepted | 4.52E-05 | 0.016 |
Pomolate-NPFF | 4.199 | 0.932 | 0.003 | 1 | 0.014 | Accepted | 1.34E-04 | 0.018 |
Sinapate-NPFF | 1.643 | 0.996 | 0.002 | 0.999 | 0.984 | Accepted | 1.02E-04 | 0.024 |
MiF-1 | − 0.367 | 0.01 | 0.137 | 0.009 | 0.83 | Accepted | 1.91E-05 | 0.032 |
Betanin-MiF-1 | − 1.373 | 0.997 | 0.102 | 0 | 0.936 | Accepted | 1.14E-04 | 0.008 |
Betanin-di-MiF-1 | − 1.148 | 0.996 | 0.089 | 0 | 0.881 | Accepted | 6.60E-05 | 0.008 |
Betanin-tri-MiF-1 | − 0.193 | 0.999 | 0.056 | 0 | 0.881 | Accepted | 4.94E-05 | 0.008 |
Gallate-MiF-1 | − 0.482 | 0.32 | 0.351 | 0.001 | 0.981 | Accepted | 3.30E-06 | 0.007 |
Pomolate-MiF-1 | 4.655 | 0.042 | 0.689 | 0.745 | 0 | Accepted | 2.97E-05 | 0.015 |
Sinapate-MiF-1 | 0.944 | 0.236 | 0.978 | 0.146 | 0.988 | Accepted | 5.65E-06 | 0.034 |